(Q31043038)

28 June 2017

Neuropeptides bombesin and calcitonin inhibit apoptosis-related elemental changes in prostate carcinoma cell lines (English)

1 reference

28 June 2017

1 reference

Mercedes Salido

1

1 reference

28 June 2017

Jose Vilches

series ordinal

2

1 reference

28 June 2017

Antonio López

series ordinal

3

1 reference

28 June 2017

Godfried M Roomans

series ordinal

4

1 reference

28 June 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

28 June 2017

1 reference

28 June 2017

94

1 reference

28 June 2017

368-377

1 reference

28 June 2017

2

1 reference

Prognostic significance of neuroendocrine differentiation in prostate cancer

28 June 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10227

Neuroendocrine differentiation in prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10227

Effects of the calciotrophic peptides calcitonin and parathyroid hormone on prostate cancer growth and chemotaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10227

Effect of somatostatin analog RC-160 and bombesin/gastrin releasing peptide antagonist RC-3095 on growth of PC-3 human prostate-cancer xenografts in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10227

Somatostatin analog RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of androgen-independent DU-145 human prostate cancer line in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10227

Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10227

Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist Cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10227

Peptide analogs in the therapy of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10227

Calcium signaling in prostate cancer cells: evidence for multiple receptors and enhanced sensitivity to bombesin/GRP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10227

Characterization of calcium release-activated apoptosis of LNCaP prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10227

Bombesin specifically induces intracellular calcium mobilization via gastrin-releasing peptide receptors in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10227

Androgen-independent growth is induced by neuropeptides in human prostate cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10227

In vitro regulation of pericellular proteolysis in prostatic tumor cells treated with bombesin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10227

Potassium is a critical regulator of apoptotic enzymes in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10227

A necessary role for reduced intracellular potassium during the DNA degradation phase of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10227

Ions, cell volume, and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10227

Calcium channel blockers, apoptosis and cancer: is there a biologic relationship?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10227

Normotonic cell shrinkage because of disordered volume regulation is an early prerequisite to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10227

Tyrosine kinase-dependent activation of a chloride channel in CD95-induced apoptosis in T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10227

X-ray microanalysis of etoposide-induced apoptosis in the PC-3 prostatic cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10227

The mitochondrial death/life regulator in apoptosis and necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10227

Changes in elemental content during apoptotic cell death studied by electron probe X-ray microanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10227

Changes in elemental concentrations are associated with early stages of apoptosis in human monocyte-macrophages exposed to oxidized low-density lipoprotein: an X-ray microanalytical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10227

Target sites for manipulating apoptosis in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10227

Signaling for the caspases: their role in prostate cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10227

Characterization of high-affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC-3 and DU-145: internalization of receptor bound 125I-(Tyr4) bombesin by tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10227

Luteinizing hormone-releasing hormone antagonist Cetrorelix (SB-75) and bombesin antagonist RC-3940-II inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10227

Induction of apoptosis in neuroendocrine tumors of the digestive system during treatment with somatostatin analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10227

A monoclonal antibody against rat calcitonin inhibits the growth of a rat medullary thyroid carcinoma cell line in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10227

Bombesin stimulates growth of human prostatic cancer cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10227

In vivo inhibition of PC-3 human androgen-independent prostate cancer by a targeted cytotoxic bombesin analogue, AN-215

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10227

Characterization of intracellular calcium mobilization by bombesin-related neuropeptides in PC-3 human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10227

A primary role for K+ and Na+ efflux in the activation of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10227

Intracellular K+ suppresses the activation of apoptosis in lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10227

Volume-induced chloride transport in HT29 cells studied by X-ray microanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10227

Quantitative X-ray microanalysis of biological specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10227

Possible involvement of a chloride-bicarbonate exchanger in apoptosis of endothelial cells and cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10227

X-ray microanalysis of psoriatic skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10227

Inhibition of growth of PC-82 human prostate cancer line xenografts in nude mice by bombesin antagonist RC-3095 or combination of agonist [D-Trp6]-luteinizing hormone-releasing hormone and somatostatin analog RC-160

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10227

21 January 2018

Identifiers

DOI

10.1002/CNCR.10227

1 reference

28 June 2017

1 reference